Mood and physical symptoms improve in women with severe cyclical changes by taking an oral contraceptive containing 250-mcg norgestimate and 35-mcg ethinyl estradiol

Contraception

Volumn 87, Issue 6, 2013, Pages 773-781

  Nyberg, Sigrid ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Combined oral contraceptive pills; Menstrual cycle; Mood; Norgestimate; Premenstrual symptoms

Indexed keywords

ETHINYLESTRADIOL PLUS NORGESTIMATE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLICULAR PHASE; HUMAN; LUTEAL PHASE; MOOD; OPEN STUDY; PREMENSTRUAL SYNDROME; PROSPECTIVE STUDY; STRUCTURED INTERVIEW;

ACTIVITIES OF DAILY LIVING; ADULT; BREAST; CONTRACEPTIVES, ORAL, COMBINED; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EDEMA; ETHINYL ESTRADIOL-NORGESTREL COMBINATION; FEMALE; HUMANS; IRRITABLE MOOD; LUTEAL PHASE; NORGESTREL; PATIENT DROPOUTS; PREMENSTRUAL SYNDROME; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; RECURRENCE; SEVERITY OF ILLNESS INDEX; SWEDEN; YOUNG ADULT;

EID: 84877693025     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2012.09.024     Document Type: Article

References (48)

1. S.A. Sanders, C.A. Graham, J.L. Bass, and J. Bancroft A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation Contraception 64 2001 51 58
2. M.J. Rosenberg, and M.S. Waugh Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons Am J Obstet Gynecol 179 1998 577 582
3. A.L. Coffee, T.J. Kuehl, S. Willis, and P.J. Sulak Oral contraceptives and premenstrual symptoms: comparison of a 21/7 and extended regimen Am J Obstet Gynecol 195 2006 1311 1319
4. T. Bäckström, Y. Hansson-Malmström, B.A. Lindhe, B. Cavalli-Björkman, and S. Nordenström Oral contraceptives in premenstrual syndrome: a randomized comparison of triphasic and monophasic preparations Contraception 46 1992 253 268
5. T.B. Pearlstein, E. Frank, A. Rivera-Tovar, J.S. Thoft, E. Jacobs, and T.A. Mieczkowski Prevalence of axis I and axis II disorders in women with late luteal phase dysphoric disorder J Affect Disord 20 1990 129 134
6. K.A. Oinonen, and D. Mazmanian To what extent do oral contraceptives influence mood and affect? J Affect Disord 70 2002 229 240
7. H. Joffe, L.S. Cohen, and B.L. Harlow Impact of oral contraceptive pill use on premenstrual mood: predictors of improvement and deterioration Am J Obstet Gynecol 189 2003 1523 1530
8. S. Hammarbäck, and T. Bäckström Induced anovulation as treatment of premenstrual tension syndrome. A double-blind cross-over study with GnRH-agonist versus placebo Acta Obstet Gynecol Scand 67 1988 159 166
9. T. Bäckström, L. Andreen, and V. Birzniece The role of hormones and hormonal treatments in premenstrual syndrome CNS Drugs 17 2003 325 342
10. B. Segebladh, A. Borgström, S. Nyberg, M. Bixo, and I. Sundström-Poromaa Evaluation of different add-back estradiol and progesterone treatments to gonadotropin-releasing hormone agonist treatment in patients with premenstrual dysphoric disorder Am J Obstet Gynecol 201 2009 139.e1 139.e8
11. P.J. Schmidt, L.K. Nieman, M.A. Danaceau, L.F. Adams, and D.R. Rubinow Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome N Engl J Med 338 1998 209 216
12. J. Cullberg Mood changes and menstrual symptoms with different gestagen/estrogen combinations. A double-blind comparison with a placebo Acta Psychiatr Scand Suppl 236 1972 1 86
13. I. Björn, M. Bixo, K.S. Nöjd, S. Nyberg, and T. Bäckström Negative mood changes during hormone replacement therapy: a comparison between two progestogens Am J Obstet Gynecol 183 2000 1419 1426
14. I. Björn, I. Sundström-Poromaa, M. Bixo, S. Nyberg, G. Bäckström, and T. Bäckström Increase of estrogen dose deteriorates mood during progestin phase in sequential hormonal therapy J Clin Endocrinol Metab 88 2003 2026 2030
15. S.J. Kutner, and W.L. Brown History of depression as a risk factor for depression with oral contraceptives and discontinuance J Nerv Ment Dis 155 1972 163 169
16. A.J. Rapkin, G. Biggio, and A. Concas Oral contraceptives and neuroactive steroids Pharmacol Biochem Behav 84 2006 628 634
17. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR) 2000 APA Washington
18. R.L. Spitzer, J.B. Williams, and K. Kroenke Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study JAMA 272 1994 1749 1756
19. S. Hammarbäck, T. Bäckström, and B. MacGibbon-Taylor Diagnosis of premenstrual tension syndrome: description and evaluation of a procedure for diagnosis and differential diagnosis J Psychosom Obstet Gynaecol 10 1989 25 42
20. P.M. ÓBrien, T. Bäckström, and C. Brown Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus Arch Womens Ment Health 14 2011 13 21
21. R. Sitruk-Ware New progestagens for contraceptive use Hum Reprod Update 12 2006 169 178
22. C.A. Graham, and B.B. Sherwin A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive J Psychosom Res 36 1992 257 266
23. T. Greco, C.A. Graham, J. Bancroft, A. Tanner, and H.A. Doll The effects of oral contraceptives on androgen levels and their relevance to premenstrual mood and sexual interest: a comparison of two triphasic formulations containing norgestimate and either 35 or 25 microg of ethinyl estradiol Contraception 76 2007 8 17
24. V. Dhar, and B.E. Murphy Double-blind randomized crossover trial of luteal phase estrogens (Premarin) in the premenstrual syndrome (PMS) Psychoneuroendocrinology 15 1990 489 493
25. J. Bancroft, D. Sanders, P. Warner, and N. Loudon The effects of oral contraceptives on mood and sexuality: a comparison of triphasic and combined preparations J Psychosom Obstet Gynecol 7 1987 1 8
26. U. Halbreich, E.W. Freeman, and A.J. Rapkin Continuous oral levonorgestrel/ethinyl estradiol for treating premenstrual dysphoric disorder Contraception 85 2012 19 27
27. R. Sitruk-Ware Progestogens in hormonal replacement therapy: new molecules, risks, and benefits Menopause 9 2002 6 15
28. M. Sillem, R. Schneidereit, R. Heithecker, and A.O. Mueck Use of an oral contraceptive containing drospirenone in an extended regimen Eur J Contracept Reprod Health Care 8 2003 162 169
29. S. Taneepanichskul, U. Jaisamrarn, and V. Phupong Efficacy of Yasmin in premenstrual symptoms Arch Gynecol Obstet 275 2007 433 438
30. A.E. Schindler, C. Campagnoli, and R. Druckmann Classification and pharmacology of progestins Maturitas 46 Suppl. 1 2003 S7 S16
31. U. Fuhrmann, R. Krattenmacher, E.P. Slater, and K.H. Fritzemeier The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential Contraception 54 1996 243 251
32. M. Wang, S. Hammarbäck, B.A. Lindhe, and T. Bäckström Treatment of premenstrual syndrome by spironolactone: a double-blind, placebo-controlled study Acta Obstet Gynecol Scand 74 1995 803 808
33. M. Sangthawan, and S. Taneepanichskul A comparative study of monophasic oral contraceptives containing either drospirenone 3 mg or levonorgestrel 150 microg on premenstrual symptoms Contraception 71 2005 1 7
34. T.B. Pearlstein, G.A. Bachmann, H.A. Zacur, and K.A. Yonkers Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation Contraception 72 2005 414 421
35. E.W. Freeman, R. Kroll, and A. Rapkin Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder J Womens Health Gend Based Med 10 2001 561 569
36. L.M. Lopez, A.A. Kaptein, and F.M. Helmerhorst Oral contraceptives containing drospirenone for premenstrual syndrome Cochrane Database Syst Rev 2 2012 CD006586
37. F.Z. Stanczyk All progestins are not created equal Steroids 68 2003 879 890
38. T. Rabe, A. Kowald, J. Ortmann, and S. Rehberger-Schneider Inhibition of scin 5 alpha-reductase by oral contraceptive progestins in vitro Gynecol Endocrinol 14 2000 223 230
39. G.L. Hammond, L.S. Abrams, G.W. Creasy, J. Natarajan, J.G. Allen, and P.K. Siiteri Serum distribution of the major metabolites of norgestimate in relation to its pharmacological properties Contraception 67 2003 93 99
40. E. Eriksson, C. Sundblad, P. Lisjö, K. Modigh, and B. Andersch Serum levels of androgens are higher in women with premenstrual irritability and dysphoria than in controls Psychoneuroendocrinology 17 1992 195 204
41. R.A. Boyd, E.A. Zegarac, E.L. Posvar, and M.R. Flack Minimal androgenic activity of a new oral contraceptive containing norethindrone acetate and graduated doses of ethinyl estradiol Contraception 63 2001 71 76
42. T. Bäckström, A. Andersson, and L. Andreen Pathogenesis in menstrual cycle-linked CNS disorders Ann N Y Acad Sci 1007 2003 42 53
43. M. Schumacher, R. Guennoun, and A. Ghoumari Novel perspectives for progesterone in hormone replacement therapy, with special reference to the nervous system Endocr Rev 28 2007 387 439
44. T. Bäckström, D. Haage, and M. Löfgren Paradoxical effects of GABA-A modulators may explain sex steroid induced negative mood symptoms in some persons Neuroscience 191 2011 46 54
45. A.J. Rapkin, M. Morgan, C. Sogliano, G. Biggio, and A. Concas Decreased neuroactive steroids induced by combined oral contraceptive pills are not associated with mood changes Fertil Steril 85 2006 1371 1378
46. S. Nyberg, T. Bäckström, E. Zingmark, R.H. Purdy, and I.S. Poromaa Allopregnanolone decrease with symptom improvement during placebo and gonadotropin-releasing hormone agonist treatment in women with severe premenstrual syndrome Gynecol Endocrinol 23 2007 257 266
47. E.W. Freeman, C.A. Frye, K. Rickels, P.A. Martin, and S.S. Smith Allopregnanolone levels and symptom improvement in severe premenstrual syndrome J Clin Psychopharmacol 22 2002 516 520
48. S.S. Girdler, P.A. Straneva, K.C. Light, C.A. Pedersen, and A.L. Morrow Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder Biol Psychiatry 49 2001 788 797